DalsnaFinance › IPOs › Fulcrum Therapeutics Inc › IPO
Fulcrum Therapeutics, Inc. completed its initial public offering on NASDAQ on July 18, 2019, pricing at $16.00 a share.
| Ticker | FULC |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | July 18, 2019 |
| Offering price | $16.00 |
| Shares offered | 4,500,000 |
| Total raised | $72M |
Fulcrum Therapeutics, Inc. sold 4,500,000 shares at $16.00 each on NASDAQ. Multiplied out, that is $72 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $72 million total recorded for the deal.
Fulcrum Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Fulcrum Therapeutics, Inc.. This page is general information, not investment advice.